CIBC Private Wealth Group’s United Therapeutics UTHR Stock Holding History

CIBC Private Wealth Group’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$445K	Buy	913 +200	+28%	+$93.1K	﹤0.01%	923
2025 Q3	$299K	Buy	713 +284	+66%	+$95.5K	﹤0.01%	1017
2025 Q2	$123K	Sell	429 -213	-33%	-$63.7K	﹤0.01%	1306
2025 Q1	$180K	Buy	642 +171	+36%	+$58.6K	﹤0.01%	1112
2024 Q4	$173K	Buy	471 +18	+4%	+$6.62K	﹤0.01%	1213
2024 Q3	$162K	Sell	453 -1,599	-78%	-$540K	﹤0.01%	1286
2024 Q2	$650K	Buy	2,052 +1,939	+1,716%	+$513K	﹤0.01%	749
2024 Q1	$25.8K	Buy	+113	New	+$25.5K	﹤0.01%	1948
2022 Q2	–	Sell	-16	Closed	-$3K	–	1303
2022 Q1	$3K	Buy	+16	New	+$3.05K	﹤0.01%	1213
2018 Q2	–	Sell	-18	Closed	-$2K	–	2097
2018 Q1	$2K	Buy	+18	New	+$2.29K	﹤0.01%	1818

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return

CIBC Private Wealth Group's UTHR Position: Q4 2025 in Review

CIBC Private Wealth Group increased its United Therapeutics (UTHR) stake by 28% in Q4 2025, buying an estimated $93.1K and bringing the position to 913 shares worth $445K. The position accounts for ﹤0.01% of the portfolio, ranked #923.

CIBC Private Wealth Group first reported a position in UTHR in Q1 2018 and has held it in 10 quarters since. The position peaked at $650K in Q2 2024. 838 funds tracked by Wall St. Rank hold UTHR as of Q4 2025.

CIBC Private Wealth Group held 913 shares of United Therapeutics worth $445K as of Q4 2025.
CIBC Private Wealth Group bought 200 United Therapeutics shares in Q4 2025, an estimated $93.1K.
United Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #923 holding.
CIBC Private Wealth Group first reported a position in United Therapeutics in Q1 2018 and has held it in 10 quarters since.
CIBC Private Wealth Group's United Therapeutics position peaked at $650K in Q2 2024.
838 funds tracked by Wall St. Rank held United Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.